David O’Reilly, director of scientific research at BAT, shares his views on the roles of science and nicotine in tobacco harm reduction.Read More
Politics and data in tobacco harm reductionRead More
Quitting vaping early but continuing to smoke was the most common pattern.Read More
More robust and diverse data will help researchers develop predictive risk factor tools.Read More
Policymakers should be wary about THP harm reduction claims, say researchers.Read More
A study sheds light on impact of reduced-nicotine mandates. Read More
Bacteroides xylanisolvens can reduce smoking-exacerbated NAFLD progression.Read More
The results are currently being analyzed and will be published by the end of the year.Read More
The firm will use the funds to develop a proof of concept and apply for FDA authorization.Read More
BioBetter uses plants as natural bioreactors to achieve the required cellular development. Read More
Recent Posts
- U.S. Market Poised for Disruption
- New KT&G CEO Engages Employees
- Sullivan and Mish Resign From 22nd Century Board
- Philip Morris Pakistan Urges Action Against Illicit Trade
- Philippines: Momentum Building for Disposables Ban
- Healthcare Providers Urged to Discuss Vapes
- Vape Shops Challenge Kentucky Registry Bill
- Smokers Ordered to Keep Their Distance
- Former BAT Company Does Ruble-Yuan Swaps
- Cuban Origin Ruling Final: Court
- Mustafa Named Influential Executive
- CTP Launches Webpage on Relative Risks
- PCA Reflects on Successful Trade Show
- Britain’s Generation Ban Passes First Vote
- PMI Eyes Philippines Leaf for Smoke-Free